Skip to main content
. 2016 Nov 25;21(12):1537. doi: 10.3390/molecules21121537

Table 3.

Overlap between drug candidates generated by the CANDO platform and those identified by Johansen et al. [28] as FDA approved actives.

Compound(s) Interaction Score Consensus Score Approved Indication Mode of Action
Niclosamide * 1.897 3 helminthic infestation inhibits parasite metabolism
Quinestrol 1.897 3 hormone replacement therapy synthetic steroidal estrogen receptor agonist
Sertraline * 1.897 1 depression, anxiety selective serotonin receptor inhibitor
Clomifene * 1.897 1 anovulation, oligoovulation selective estrogen receptor modulator
Propoxyphene 1.897 1 mild to moderate pain opiate receptor binder
Atovaquone 1.897 1 pneumocystis Pneumonia dihydroorotate dehydrogenase inhibitor
Azelastine 1.897 1 allergic rhinitis H1 histamine receptor inhibitor
Danazol 1.897 1 endometriosis androgen receptor competitive inhibitor
Mebendazole * 1.897 1 helminthic infestation tubulin destabilizer
Hydroxyprogesterone 1.823 2 preterm labor steroidal progesterone receptor agonist
Deslanoside * 1.377 10 cardiac arrhythmia sodium-potassium channel blocker
Digoxin * 1.067 1 cardiac arrhythmia sodium-potassium channel blocker
Ritonavir 1.057 2 HIV infection protease inhibitor
Raloxifene * 0.843 2 osteoporosis and breast cancer prevention selective estrogen receptor modulator
Ciclesonide 0.843 1 asthma, allergic rhinitis glucocorticoid receptor agonist
Clemastine * 0.741 1 allergies H1 histamine receptor inhibitor
Podofilox 0.741 1 skin warts caused by Human papilloma virus tubulin polymerization inhibitor
Tamoxifen * 0.741 1 estrogen receptor + breast cancer selective estrogen receptor modulator
Desloratadine 0.741 1 allergies H1 histamine receptor inhibitor
Methdilazine 0.741 1 allergy symptoms, antiemetic H1 histamine receptor antagonist
Chlorcyclizine 0.741 1 allergy symptoms, antiemetic H1 histamine receptor antagonist
Azacitidine 0.712 1 myelodysplastic syndrome DNA methyl transferase inhibitor
Terconazole 0.711 1 fungal infection ERG11/CYP51 inhibitor
Bromocriptine 0.707 1 pituitary tumors, Parkinson’s disease dopamine receptor agonist

* Drugs also identified by Kouznetsova et al. [27].